[Practice review on the use of proton pump inhibitors]

Proton pump inhibitors (PPI), these antacid drugs that have revolutionized the treatment of peptic disease, have become, in the daily practice of primary care physicians as well as hospital practitioners, an inescapable treatment since their introduction on the market in 1989, and even the 4th most prescribed drug class in Switzerland. Therefore, multiple studies as well as numerous recommendations and expert opinions on their effectiveness and use have been -published. This article will present their proper use, by reviewing the knowledge available to date on these essential drugs in our -therapeutic arsenal.